GlassScriptPhysician profile
Steven Sterzer
NPI 1487691630
$1,387.73
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $164 · 2021: $287 · 2022: $425 · 2023: $304 · 2024: $15.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $220 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.43 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $372.64 | 2019-2023 | Xtandi |
| Abbvie INC. | $306.59 | 2019-2024 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $183.53 | 2019-2023 | Erleada, Akeega |
| Procept Biorobotics Corporation | $169.67 | 2022 | |
| Allergan, INC. | $125.29 | 2019-2021 | |
| Pfizer INC. | $87.39 | 2019-2023 | |
| Teleflex LLC | $75.35 | 2022 | |
| Urovant Sciences INC | $32.75 | 2022 | |
| Coloplast Corp | $22.92 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Sterzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.